Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immune Therapeutics Inc (IMUN)

Immune Therapeutics Inc (IMUN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immune Therapeutics Inc 2431 ALOMA AVENUE SUITE 124 WINTER PARK FL 32792 USA

www.biostaxcorp.com P: 888-613-8802

Description:

Forte Biotechnology Intl Corp is a biotechnology company. Its goal is to acquire late stage modulator drugs and immune modulator biopharmaceuticals for cancer, chronic inflammation, pain and neurodegenerative disease in companion pets. Forte Biotechnology Intl Corp, formerly known as Immune Therapeutics Inc., is based in Fort Collins Colorado.

Key Statistics

Overview:

Market Capitalization, $K 7,780
Enterprise Value, $K 7,630
Shares Outstanding, K 83,658
Annual Sales, $ 0 K
Annual Net Income, $ -3,540 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -500 K
EBIT, $ -1,480 K
EBITDA, $ -1,450 K
60-Month Beta 0.46
% of Insider Shareholders 50.59%
% of Institutional Shareholders 0.00%
Float, K 41,335
% Float 49.41%
Short Volume Ratio 0.40

Growth:

1-Year Return -93.16%
3-Year Return -99.67%
5-Year Return -99.51%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 11/14/22
Latest Earnings Date 11/13/23
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Year -116.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-1000 on 05/06/21

IMUN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -544.75%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -28.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar